Rare disease advocacy groups selected to collect patients’ data
Four rare disease advocacy groups have been chosen by the National Organization for Rare Disorders (NORD) to take part in IAMRARE, a program that will help them launch their own patient-powered natural history studies. Rare diseases, including cold agglutinin disease (CAD) often are poorly understood, and there…